Back to Search Start Over

Study protocol for Care cOORDInatioN And sympTom managEment (COORDINATE) programme: a feasibility study.

Authors :
Koirala, B
Badawi, S
Frost, S
Ferguson, C
Hager, DN
Street, L
Perrin, N
Dennison Himmelfarb, C
Davidson, P
Koirala, B
Badawi, S
Frost, S
Ferguson, C
Hager, DN
Street, L
Perrin, N
Dennison Himmelfarb, C
Davidson, P
Publication Year :
2023

Abstract

INTRODUCTION: Sustainable approaches to support care coordination and symptom management needs of critically ill adults living with multimorbidity are needed to combat the challenges and complexity that multimorbidity presents. The study aims to test the feasibility of the Care cOORDInatioN And sympTom managEment (COORDINATE) intervention to improve health outcomes of adults living with multimorbidity. METHODS AND ANALYSIS: A multicomponent nurse-driven intervention was developed using experience-based co-design and human-centred design. Inclusion criteria include (1) age 55 years and older, (2) admitted to an intermediate care unit, (3) presence of two or more chronic health conditions and (4) signed informed consent. Data collection will occur at baseline (time of recruitment predischarge) and 6 weeks and 3 months following hospital discharge. Outcome of interest from this feasibility study is to evaluate the financial, technical and logistic feasibility of a full-scale study including data collection and protocol adherence. Additionally, Cohen's d effect sizes for the change in outcomes over time will be computed to establish power calculations required for a full-scale study. The protocol was prepared in accordance with Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist. ETHICS AND DISSEMINATION: The study has been reviewed and approved by the Institutional Review Board of Johns Hopkins Medical Institutions. Given the success of this feasibility study, the potential for the COORDINATE intervention to decrease the symptom burden and improve participant quality of life among critically ill people with multimorbidity will be tested in a full-scale study, and findings will be actively disseminated. TRIAL REGISTRATION NUMBER: NCT05985044.

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1426935808
Document Type :
Electronic Resource